Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
Abstract
Programmed death 1 (PD-1) blockade has clinical benefit in microsatellite-instability–high (MSI-H) or mismatch-repair–deficient (dMMR) tumors after previous therapy. The efficacy of PD-1 blockade as compared with chemotherapy as first-line therapy for MSI-H–dMMR advanced or metastatic colorectal cancer is...
Paper Details
Title
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
Published Date
Dec 3, 2020
Volume
383
Issue
23
Pages
2207 - 2218
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History